हिंदी में पढ़ें

Mankind Pharma

Should you buy HDFC Bank, Trent, Mankind or ABB shares for long term now?

Should you buy HDFC Bank, Trent, Mankind or ABB shares for long t...

Mon, Apr 21, 2025

Which stocks should you buy for the long term now? Zee Business analysts Ashish Chaturvedi and Pooja Tripathi have prepared a list of buzzing stocks on Dalal Street and shared their intraday, short- and long-term calls for them. Read on to learn about their views on more than a dozen scrips.

Mankind Pharma faces over Rs 2-crore penalty from GST authority

Mankind Pharma faces over Rs 2-crore penalty from GST authority

Wed, Jan 15, 2025

The company has received an order on January 14, 2025 from Office of the Commissioner of Kolkata South CGST & CX -- issued by Additional Commissioner, Mankind Pharma said in a regulatory filing.

Mankind Pharma shares rise as profits jump 29% in Q2 on strong sales recovery

Mankind Pharma shares rise as profits jump 29% in Q2 on strong s...

Wed, Nov 06, 2024

Mankind Pharma, one of India’s largest pharmaceutical players, witnessed its shares surge by 6 per cent to a peak of Rs 2,882.75 on the BSE after announcing a robust 29 per cent year-on-year profit

TRENDING NOW

Mankind Pharma Q2 Results: Net profit rises 29% to Rs 659 crore; revenue up 13.6%

Mankind Pharma Q2 Results: Net profit rises 29% to Rs 659 crore;...

Tue, Nov 05, 2024

Mankind Pharma Q2 Results: Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658.88 crore for the second quarter ended September 2024, helped by recovery in volume.

Mankind Pharma completes Rs 13,768 crore BSV acquisition

Mankind Pharma completes Rs 13,768 crore BSV acquisition

Thu, Oct 24, 2024

BSV, has developed recombinant and niche biologic products in-house, demonstrating its strong R&D capabilities and boasts of a robust branded product portfolio across women's health, fertility, critical care and immunoglobulins.

Mankind Pharma to raise up to Rs 10,000 crore through bonds

Mankind Pharma to raise up to Rs 10,000 crore through bonds

Fri, Sep 20, 2024

Mankind Pharma's board on Friday approved a proposal to raise up to Rs 10,000 crore through bonds.

Mankind Pharma board to meet this week to consider fund raising

Mankind Pharma board to meet this week to consider fund raising

Wed, Sep 18, 2024

The company, however, did not mention the amount it seeks to raise through the issue of securities.

Mankind Pharma to acquire Bharat Serums and Vaccines for Rs 13,630 crore

Mankind Pharma to acquire Bharat Serums and Vaccines for Rs 13,63...

Fri, Jul 26, 2024

The company has entered into a definitive agreement with Advent to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

Which stocks will be in focus today Raymond, Bajaj Consumer Care, Zydus Lifesciences Ltd & Mankind Pharma?

Which stocks will be in focus today Raymond, Bajaj Consumer Care,...

Thu, Jul 11, 2024

Which stocks will be in focus today Raymond, Bajaj Consumer Care, Zydus Lifesciences Ltd & Mankind Pharma? News shares and triggers. Know about Stocks In News.

Vedanta, Bajaj Healthcare, Poly cab & Mankind Pharma, which stocks will be in focus today?

Vedanta, Bajaj Healthcare, Poly cab & Mankind Pharma, which s...

Wed, Jul 10, 2024

Vedanta, Bajaj Healthcare, Poly cab & Mankind Pharma, which stocks will be in focus today? News shares and triggers. Know in Stocks In News.

Block deals: 0.9% equity changes hands in Mankind Pharma; Hema CIPEF likely seller

Block deals: 0.9% equity changes hands in Mankind Pharma; Hema C...

Wed, Jul 10, 2024

As 0.9 per cent equity changed hands in the pre-opening deal, shares of Mankind Pharma will gain focus today.

Stock of the day : Anil Singhvi recommends buying Ambuja Cement Futures & Mankind Pharma

Stock of the day : Anil Singhvi recommends buying Ambuja Cement F...

Thu, Jun 13, 2024

Stock of the Day; Today Anil Singhvi gave buying advice in Ambuja Cement Futures & Mankind Pharma. What is stoploss and targets? See in this video.

Stock of the day: Anil Singhvi gives buying opinion in Mankind Pharma

Stock of the day: Anil Singhvi gives buying opinion in Mankind Ph...

Thu, May 16, 2024

Stock of the Day: Today Anil Singhvi gave buying opinion in Mankind Pharma...What is the stoploss and targets? See in this video...

This pharma stock jumps over 4% after strong Q4 results - Check new targets by Anil Singhvi

This pharma stock jumps over 4% after strong Q4 results - Check n...

Thu, May 16, 2024

Mankind Pharma Share Price Target, Mankind Pharma Share 4 Results: Revenue from operations rose to Rs 2,441 crore in the period under review from Rs 2,053 crore in the year-ago period, Mankind Pharma said in a statement.

Mankind Pharma Q4 results: Net profit rises 62% to Rs 477 crore

Mankind Pharma Q4 results: Net profit rises 62% to Rs 477 crore

Wed, May 15, 2024

Revenue from operations rose to Rs 2,441 crore in the period under review from Rs 2,053 crore in the year-ago period, Mankind Pharma said in a statement.

Bosch, Mankind Pharma among 12 stocks that may enter MSCI Global Standard Index in May

Bosch, Mankind Pharma among 12 stocks that may enter MSCI Global...

Thu, Apr 18, 2024

Which stocks will be entered in MSCI? Where will the investment come from entry in MSCI? Which stocks will be out of MSCI? Know complete details in this video

D-Street Newsmakers: Mankind Pharma, Max Financial and Spicejet among 10 stocks that made headlines today

D-Street Newsmakers: Mankind Pharma, Max Financial and Spicejet...

Tue, Mar 26, 2024

Nifty at the close gave up 92.05 points, or 0.42 per cent, and ended at 22,004.7, while Sensex fell 361.64 points, or 0.5 per cent, and settled at 72,470.30.

Mankind Pharma shares decline over 3% after 1.19 crore shares change hands in block deals

Mankind Pharma shares decline over 3% after 1.19 crore shares cha...

Tue, Mar 26, 2024

Mankind Pharma share price NSE BSE, Mankind Pharma block deals: Beige Limited, a private equity firm affiliated with ChrysCapital, is the likely seller. The size of the deal, as per Zee Business Research, was Rs 2,450 crore.

Mankind Pharma: This pharma stock has potential to double your money in 3-4 years - Check Anil Singhvi's View

Mankind Pharma: This pharma stock has potential to double your mo...

Fri, Mar 22, 2024

Mankind Pharma Share Price Target: Anil Singhvi said that Mankind Pharma has a stronghold in the pharma market as they have around 40 brands, many of which are market leaders.

Mankind Pharma jumps over 5% after promoters announce selling their 1.62% stake through block deal

Mankind Pharma jumps over 5% after promoters announce selling the...

Thu, Feb 08, 2024

Promoters of Mankind Pharma will sell their 1.62% stake, or 64.90 lakh shares, through the block deal. The floor price of the share has been fixed at Rs 2050/share for the deal.

Mankind Pharma Q3 Results: Net profit jumps 55% to Rs 460 crore

Mankind Pharma Q3 Results: Net profit jumps 55% to Rs 460 crore

Wed, Jan 31, 2024

Mankind Pharma Q3 Results: Mankind Pharma on Wednesday said its consolidated net profit increased 55 per cent to Rs 460 crore for the third quarter ended December 2023.

Mankind Pharma shares hit fresh 52-week high - Buy, Sell or Hold? Check target

Mankind Pharma shares hit fresh 52-week high - Buy, Sell or Hold?...

Thu, Jan 11, 2024

Mankind Pharma Share Price: According to Kunal Saraogi of Equityrush, investors should buy this pharma stock at every dip.

Mankind Pharma declines over 4% after announcing block deal worth Rs 4935 crore

Mankind Pharma declines over 4% after announcing block deal worth...

Tue, Dec 12, 2023

Big Block Deal in MankindPharma - What are the chances of getting included in MSCI index? Floor price of block deal is ₹ 1785.65/share. If it gets included in MSCI, it will be a big investment? - Know the complete details from Varun...

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x